clinical trial · NCT07589738
A Prospective, Randomized, Blind, Controlled Multicenter Clinical Study Comparing the Effectiveness of Preventive Ventricular Arrhythmia Ablation on the Prognosis After Left Ventricular Assist Device (LVAD) Surgery.
The First Affiliated Hospital of Anhui Medical University·N/A·active not recruiting·n = 90
CHF - Congestive Heart Failurepreventive ablation group
brief summary
To compare the preventive effect of preventive ventricular arrhythmia ablation on the composite events 30 days after surgery in the study population. The composite events defined in this study 30 days after surgery include persistent ventricular tachycardia/ventricular fibrillation, all-cause death, mechanical thrombosis and right heart failure.
started
Jan 31, 2026
primary completion
Sep 30, 2028
completion
Sep 30, 2028
last updated
May 15, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol